These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 3938829
1. [The effect of synthetic gonadotropin releasing hormone on the plasma levels of FH and LSH in women with hirsutism and polycystic ovaries]. Pjević M, Kovac T, Bujas M, Pusac R. Jugosl Ginekol Perinatol; 1985; 25(3-4):49-52. PubMed ID: 3938829 [Abstract] [Full Text] [Related]
2. [Inappropriate gonadotropin secretion in the polycystic ovary syndrome]. Pilotti L, Data PG, Di Tano G. Boll Soc Ital Biol Sper; 1984 Oct 30; 60(10):1885-90. PubMed ID: 6440582 [Abstract] [Full Text] [Related]
4. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects. Meczekalski B, Slopien R, Warenik-Szymankiewicz A. Eur J Obstet Gynecol Reprod Biol; 2007 May 30; 132(1):88-92. PubMed ID: 16979812 [Abstract] [Full Text] [Related]
6. [Relation between hyperprolactinemia and polycystic ovary syndrome]. Hámori M, Szendei G, Kovács I, Somos P. Zentralbl Gynakol; 1987 May 30; 109(8):481-6. PubMed ID: 3111126 [Abstract] [Full Text] [Related]
8. Effect of a dopaminergic drug on LH, FSH and prolactin levels in PCO syndrome. Venturini PL, Alibrandi MP, Costantini S, Gaggero G, Penna L, Valenzano M, Ragni N. Acta Eur Fertil; 1981 Sep 30; 12(3):295-7. PubMed ID: 6803505 [No Abstract] [Full Text] [Related]
9. Assessment of insulin resistance in the idiopathic hirsutism. Sarac F, Saygili F, Ozgen G, Tuzun M, Yilmaz C, Kabalak T. Gynecol Obstet Invest; 2007 Sep 30; 63(3):126-31. PubMed ID: 17057397 [Abstract] [Full Text] [Related]
10. Study of the source(s) of hyperandrogenism in women with idiopathic hirsutism. Leite V, Devesa J, Valdés L, Sobrinho LG. Horm Metab Res; 1990 Sep 30; 22(9):499-503. PubMed ID: 2147915 [Abstract] [Full Text] [Related]
11. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant? Milsom SR, Sowter MC, Carter MA, Knox BS, Gunn AJ. BJOG; 2003 Aug 30; 110(8):760-4. PubMed ID: 12892688 [Abstract] [Full Text] [Related]
12. [Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria]. Xu XH, Tan YC, Shi YH, Wang B, Ju XQ, Zheng QM, Hao CF, Chen ZJ. Zhonghua Yi Xue Za Zhi; 2009 Oct 13; 89(37):2604-6. PubMed ID: 20137675 [Abstract] [Full Text] [Related]
13. Serum LH levels in the differential diagnosis of hirsute anovulatory women. Oppermann K, Cho MM, Spritzer PM. Braz J Med Biol Res; 1993 Aug 13; 26(8):799-803. PubMed ID: 8298514 [Abstract] [Full Text] [Related]
14. Gonadotropin releasing hormone test: diagnostic significance and limits in menstrual pathology. Venturoli S, Nardi M, De Aloysio D, Magrini O, Flamigni C. Acta Eur Fertil; 1976 Mar 13; 7(1):1-38. PubMed ID: 785926 [Abstract] [Full Text] [Related]
15. [Relations between polycystic ovary and idiopathic hirsutism]. Montesanti F, Rama GP, Francia G, Adami S, Lo Cascio V. G Clin Med; 1988 Mar 13; 69(3):183-5. PubMed ID: 2971587 [No Abstract] [Full Text] [Related]
16. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study. Graña-Barcia M, Liz-Lestón J, Lado-Abeal J. Fertil Steril; 2005 May 13; 83(5):1466-72. PubMed ID: 15866586 [Abstract] [Full Text] [Related]
17. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria. Naessén S, Carlström K, Garoff L, Glant R, Hirschberg AL. Gynecol Endocrinol; 2006 Jul 13; 22(7):388-94. PubMed ID: 16864149 [Abstract] [Full Text] [Related]